Alba Font-Tello

8PUBLICATIONS
140CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyPredictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 12, 2025
Discovery of BMS-986408, a First-In-Class Dual DGKα and DGKζ Inhibitor that Unleashes PD-1 Checkpoint and CAR T-cell Immunotherapies.

Michael Wichroski, Si-Qi Liu, Lauren M Zasadil

|Jul 14, 2023
Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor-Positive Breast Cancer.

Francisco Hermida-Prado, Yingtian Xie, Shira Sherman

|Aug 11, 2022
A Distinct Chromatin State Drives Therapeutic Resistance in Invasive Lobular Breast Cancer.

Agostina Nardone, Xintao Qiu, Sandor Spisak

|Nov 24, 2021
Predicting master transcription factors from pan-cancer expression data.

Jessica Reddy, Marcos A S Fonseca, Rosario I Corona

|Oct 02, 2021
Subtype heterogeneity and epigenetic convergence in neuroendocrine prostate cancer.

Paloma Cejas, Yingtian Xie, Alba Font-Tello

|Sep 16, 2020
ERG-Mediated Coregulator Complex Formation Maintains Androgen Receptor Signaling in Prostate Cancer.

Neel Shah, Nikolas Kesten, Alba Font-Tello

Pageof 2

Frequent Collaborators

6 joint publications

Henry W Long

4 joint publications

Xintao Qiu

4 joint publications

Matthew L Freedman

2 joint publications

Agostina Nardone